VEGF biosimilar has moved closer to European approval for several vision-threatening retinal diseases, including choroidal neovascularization.

Blinding diseases seriously affect quality of life. Retinal and choroidal diseases are common blinding eye diseases with complicated pathogenesis that highly damage visual function. The key factor ...

Please provide your email address to receive an email when new articles are posted on . Continuous growth of macular neovascularization size, as well as development of outer retina atrophy, was ...

Both the retina as a whole and separate retinal layers had a reduction in retinal thickness after the use of anti-vascular endothelial growth factor (VEGF) treatments. Retinal thickness was ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Please provide your email address to receive an email when new articles are posted on . Patients with inherited retinal diseases may present with seemingly routine conditions. Look for comorbid ...

Neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) are the leading causes of vision impairment in elderly patients and people living with diabetes, respectively.

New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ...